BI 891065

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 891065, covering 2024-10-09 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread [Phase 1]

See pricing